Metrics as of 10/15/2026, 05:17 PM (Berlin time), refresh in progress.
Olema Pharmaceuticals Stock
Olema Pharmaceuticals, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Sean Bohen
- Employees
- 150
- Market cap
- $592 M
- IPO
- 19/11/2020
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in…
Olema Pharmaceuticals stock: price history
1D
+0.4%
1W
-12.7%
1M
-30.2%
6M
-58.6%
YTD
-72.7%
1Y
-34.1%
2Y
-41.4%
5Y
-77.8%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~3% weaker price swings than usual
Ask the agents about Olema Pharmaceuticals
Analyst assessment of Olema Pharmaceuticals
PRICE TARGET LOW
US$20.00
CONSENSUS
US$28.33
MEDIAN
US$30.00
PRICE TARGET HIGH
US$35.00
0
STRONG BUY
9
BUY
0
HOLD
0
SELL
0
STRONG SELL
9
TOTAL · Buy
As of: 14/09/2026
Olema Pharmaceuticals stock metrics
P/E
-3.22
P/B
1.65
EV/EBITDA
-2.69
RETURN ON EQUITY
-14.7%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
80.3%
FLOAT SHARES
70,293,034
AVG. DAILY VOLUME (30D)
1,227,468
Insider transactions (SEC)
Harmon Cyrus
Harmon Cyrus
Institutional holders
Comparable stocks
Frequently asked questions about Olema Pharmaceuticals stock
What does Olema Pharmaceuticals do?
Olema Pharmaceuticals, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Sean Bohen, the company employs around 150 people.
The IPO was on 19/11/2020; the stock trades on NASDAQ under the ticker OLMA.
What do analysts say about Olema Pharmaceuticals stock?
9 analysts rate the stock, the consensus is Buy (as of 14/09/2026).
The average price target is US$28.33, ranging from US$20.00 to US$35.00, with a median of US$30.00.
This is an external assessment, not a statement by Market Jury.
When does Olema Pharmaceuticals report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly -3% stronger than usual.
Does Olema Pharmaceuticals pay a dividend?
No, Olema Pharmaceuticals currently does not pay a dividend.
Which stocks are comparable to Olema Pharmaceuticals?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Olema Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess Olema Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.